ACHIEVE study finds hearing aids cut cognitive decline by 48%
The study examined 977 adults from sites across four US states and found that the use of a hearing aid with patients at risk of cognitive decline slowed loss of cognitive abilities.
29 January 2024
29 January 2024
The study examined 977 adults from sites across four US states and found that the use of a hearing aid with patients at risk of cognitive decline slowed loss of cognitive abilities.
The Valkyrie RIB system, made from PEEK, is designed to securely hold bones together whilst still offering some flexibility.
One biomarker, in particular, the peptide hormone NT-proBNP, was highlighted as a promising risk marker.
Abbott’s Libera RC deep brain stimulation (DBS) device can be used to treat movement disorders including Parkinson's disease and essential tremors.
Onward’s non-invasive neuromodulation therapy, which is FDA breakthrough device designated, has shown positive results in a pivotal trial.
Mindray’s subsidiary will purchase a 21.12% stake in APT from existing shareholders, including funds linked to Qiming Venture.
Sechrist’s eHEAL and 3300HM products are expected to enhance treatment efficiency and patient safety.
The Mister Tendon Harvester System is designed for tendon transfer procedures, particularly in flatfoot reconstruction.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.